Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CTCX

Carmell (CTCX)

Carmell Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTCX
FechaHoraFuenteTítuloSímboloCompañía
11/04/202415:30GlobeNewswire Inc.Carmell Announces Successful Closing of $3.0 Million Private PlacementNASDAQ:CTCXCarmell Corporation
04/04/202407:30GlobeNewswire Inc.Carmell Announces $3.0 Million Private PlacementNASDAQ:CTCXCarmell Corporation
27/03/202408:15GlobeNewswire Inc.Carmell Announces Successful Closing of Axolotl Biologix Sale TransactionNASDAQ:CTCXCarmell Corporation
20/03/202415:39GlobeNewswire Inc.Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix SubsidiaryNASDAQ:CTCXCarmell Corporation
18/03/202414:16GlobeNewswire Inc.Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics FieldNASDAQ:CTCXCarmell Corporation
26/02/202407:30GlobeNewswire Inc.Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024NASDAQ:CTCXCarmell Corporation
05/01/202415:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTCXCarmell Corporation
19/12/202316:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
08/12/202315:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
16/11/202307:30GlobeNewswire Inc.Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of DirectorsNASDAQ:CTCXCarmell Corporation
15/11/202315:56Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CTCXCarmell Corporation
25/10/202315:02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CTCXCarmell Corporation
12/09/202311:35PR Newswire (US)Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative MedicineNASDAQ:CTCXCarmell Corporation
05/09/202317:03GlobeNewswire Inc.Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on AestheticsNASDAQ:CTCXCarmell Corporation
14/08/202316:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTCXCarmell Corporation
09/08/202314:41Business WireCarmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand IdentityNASDAQ:CTCXCarmell Corporation
07/08/202316:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CTCXCarmell Corporation
27/07/202306:00Business WireCarmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine CompanyNASDAQ:CTCXCarmell Corporation
 Showing the most relevant articles for your search:NASDAQ:CTCX

Su Consulta Reciente

Delayed Upgrade Clock